Bleeding complications of thromboprophylaxis with dabigatran, nadroparin or rivaroxaban for 6 weeks after total knee arthroplasty surgery: a randomised pilot study

OBJECTIVES: For the non-vitamin-K oral anticoagulants, data on bleeding when used for 42 days as thromboprophylaxis after total knee arthroplasty (TKA) are scarce. This pilot study assessed feasibility of a multicentre randomised clinical trial to evaluate major and clinically relevant non-major ble...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMJ Open
Hlavní autoři: van der Veen, Lucia, Segers, Marijn, van Raay, Jos JAM, Gerritsma-Bleeker, Carina LE, Brouwer, Reinoud W, Veeger, Nic JGM, van Hulst, Marinus
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2021
Témata:
Pharmacology and Therapeutics
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7813324/
https://ncbi.nlm.nih.gov/pubmed/33462096
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2020-040336
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky